Short answer
CapsoVision, Inc (CV) filed an 8-K current report with the SEC on July 2, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Dr. Shields appointed independent Class I director and Compensation Committee member, immediately replacing Dr. Imperial.
CapsoVision, Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Dr. Shields appointed independent Class I director and Compensation Committee member, immediately replacing Dr. Imperial
- Shields brings nearly two decades of capsule-endoscopy experience, strengthening clinical expertise relevant to CapsoVision’s technology
- Shields consulting agreement: $600 per hour for up to 3 hours weekly, alongside standard director compensation
- Imperial resigned without disagreement and remains an independent consultant at $600 per hour for up to 5 hours weekly
- Imperial received a 10,000-share option at July 2, 2026 fair value, with four-year monthly vesting after 25% initial vesting
Item 7.01 · Regulation FD Disclosure
- Dr. Shields appointed to CapsoVision’s Board, adding a new director to governance oversight
- Dr. Imperial resigned from the Board, creating a change in board composition
- Press release dated July 2, 2026 provides additional background in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- Dr. David S. Shields appointed director effective July 1, 2026, adding more than 40 years of gastroenterology expertise
- Longtime clinical advisor since 2017 brings nearly two decades of capsule-endoscopy experience to board oversight
- Appointment supports anticipated AI-assisted CapsoCam Plus® launch and second-generation CapsoCam Colon™ development
- Joanne C. Imperial leaves the board but remains an independent clinical consultant for pancreatic cancer and planned 2027 esophageal-varices programs
- Pipeline milestones remain forward-looking, dependent on regulatory clearance, clinical success, financing and market conditions
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CapsoVision, Inc 8-K filings
Get the next CV 8-K as it lands
Follow CV for push alerts, or ask the research agent what this filing means.